Background <p>Vasorin (VASN) is linked to tumor progression in various cancers, its role and regulatory mechanisms in gastric cancer (GC) are still unknown.</p> Methods <p>Human gastric mucosal samples, VASN heterozygous-deficient (VASN<sup>+/-</sup>) C57BL/6 mice, and gastric cell lines with VASN knockdown and overexpression were used to study VASN’s role in GC. A combination of in vitro and in vivo models, RNA sequencing (RNA-seq), proteomics, bioinformatics, and various assays revealed VASN’s critical involvement in GC.</p> Results <p>Elevated VASN expression was significantly associated with poor clinical outcomes in GC patients. We identified a strong correlation between increased VASN expression, driven by <i>Helicobacter pylori</i> (<i>H. pylori</i>) infection, and the progression of gastric carcinogenesis. Functional studies demonstrated that VASN overexpression enhanced the proliferation, migration, and invasion of gastric epithelial cells, whereas VASN knockdown suppressed these malignant phenotypes. Mechanistically, the collagen type IV alpha 1 chain (COL4A1) was identified as a critical downstream effector of VASN in GC. VASN exerted its oncogenic effects by regulating COL4A1 to activate the PI3K/AKT signaling pathway. Furthermore, <i>H. pylori</i> infection was demonstrated to induce hypoxia-inducible factor-1 alpha (HIF-1α) expression, which subsequently upregulated VASN.</p> Conclusions <p>The HIF-1α-VASN-COL4A1-PI3K/AKT signaling pathway is crucial for gastric tumor development and may represent a therapeutic target for GC.</p> <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

VASN drives gastric tumorigenesis via activation of the COL4A1/PI3K/AKT axis during Helicobacter pylori infection

  • Rulin Zhao,
  • Jun Xie,
  • Hao Chen,
  • Xiaomin Gong,
  • Chao Peng,
  • Jinliang Xie,
  • Jianxiang Peng,
  • Jiayu Qiu,
  • Chengyun Wu,
  • Dingwei Liu,
  • Wenjie Ding,
  • Xidong Wu,
  • Sihai Chen,
  • Xiaoling Gong,
  • Huan Wang,
  • Jianfang Rong,
  • Jianping Liu,
  • Yong Xie

摘要

Background

Vasorin (VASN) is linked to tumor progression in various cancers, its role and regulatory mechanisms in gastric cancer (GC) are still unknown.

Methods

Human gastric mucosal samples, VASN heterozygous-deficient (VASN+/-) C57BL/6 mice, and gastric cell lines with VASN knockdown and overexpression were used to study VASN’s role in GC. A combination of in vitro and in vivo models, RNA sequencing (RNA-seq), proteomics, bioinformatics, and various assays revealed VASN’s critical involvement in GC.

Results

Elevated VASN expression was significantly associated with poor clinical outcomes in GC patients. We identified a strong correlation between increased VASN expression, driven by Helicobacter pylori (H. pylori) infection, and the progression of gastric carcinogenesis. Functional studies demonstrated that VASN overexpression enhanced the proliferation, migration, and invasion of gastric epithelial cells, whereas VASN knockdown suppressed these malignant phenotypes. Mechanistically, the collagen type IV alpha 1 chain (COL4A1) was identified as a critical downstream effector of VASN in GC. VASN exerted its oncogenic effects by regulating COL4A1 to activate the PI3K/AKT signaling pathway. Furthermore, H. pylori infection was demonstrated to induce hypoxia-inducible factor-1 alpha (HIF-1α) expression, which subsequently upregulated VASN.

Conclusions

The HIF-1α-VASN-COL4A1-PI3K/AKT signaling pathway is crucial for gastric tumor development and may represent a therapeutic target for GC.